In our study, the ccRCC-derived cell lines released variable amounts of PRDX2, despite consistently decreased mRNA expression in ccRCC cell lines and tumor tissues (Figs. 1 and 2). The gene discussed is PRDX2; the disease is nonpapillary renal cell carcinoma.